ARCAPTA NEOHALER*
Brand:
ARCAPTA NEOHALER*
Manufacturer:
GENERIC*
Manufacturer Details
GENERIC*
USA AND CANADA
Compositions:
Indacaterol inhalational powder- mg,
|
Strength
|
Rate
|
Packing Style
|
|
mg
|
0.00
|
unit
|
List of Related Indications:
- Long term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) including bronchitis and emphysema
List Of Drugs:
- Indacaterol Inhalation powder- Arcapta Neohaler- Respiratory- (FDC- List ) (Apr 2010)
Indication Type Description:
Indication:
Drug Name- Arcapta Neohaler
Active Ingredient - Indocaterol Inhalation powder
For the long term, once daily maintenance bronchodilator treatment
of airflow obstruction in people with chronic pulmonary disease (COPD) including
bronchitis and/or emphysema
Indication-
Long term, once daily maintenance bronchodilator treatment
of airflow obstruction in people with chronic pulmonary disease (COPD) including
bronchitis and/or emphysema
Approved by FDA on 01-7-2011 (Ref- FDA approved List- 2011)
New drugs approved For Marketing by Drug Controller General of India(DCGI )
during the period January 1988 to November 2014
(Ref- IDMA Annual Publication 2015)
Name of Drug Indication Date of Approval
Indacatterol Maleate inhalation 24-04-2010
powder hard capsules 150/300mg
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
Each capsule contains : 22-07-2014
Indaatrol Maleate 110mcg
Glycopyrronium Bromide 50mcg inhalation powder
Hard gelatin capsules
A once daily maintenance bronchodilator treatment to relieve
symptoms and reduce exacerbations in patients with chronic
Obstructive pulmonary disease COPD
